FCN3 functions as a tumor suppressor of lung adenocarcinoma through induction of endoplasmic reticulum stress.
Haeyeon JangYukyung JunSuyeon KimEunjeong KimYeonjoo JungByung Jo ParkJinseon LeeJhingook KimSanghyuk LeeJaesang KimPublished in: Cell death & disease (2021)
In this study, we report a novel function of FCN3 (Ficolin 3), a secreted lectin capable of activating the complement pathway, as a tumor suppressor of lung adenocarcinoma (LUAD). First, the expression of FCN3 was strongly down-regulated in cancer tissues compared to matched normal lung tissues, and down-regulation of FCN3 was shown to be significantly correlated with increased mortality among LUAD patients. Interestingly, while ectopic expression of FCN3 led to cell cycle arrest and apoptosis in A549 and H23 cells derived from LUAD, the secreted form of the protein had no effect on the cells. Rather, we found evidence indicating that activation of the unfolded protein response from endoplasmic reticulum (ER) stress is induced by ectopic expression of FCN3. Consistently, inhibition of ER stress response led to enhanced survival of the LUAD cells. Of note, the fibrinogen domain, which is not secreted, turned out to be both necessary and sufficient for induction of apoptosis when localized to ER, consistent with our proposed mechanism. Collectively, our data indicate that FCN3 is a tumor suppressor gene functioning through induction of ER stress.
Keyphrases
- cell cycle arrest
- endoplasmic reticulum stress
- induced apoptosis
- cell death
- pi k akt
- endoplasmic reticulum
- poor prognosis
- signaling pathway
- binding protein
- oxidative stress
- gene expression
- type diabetes
- ejection fraction
- newly diagnosed
- cardiovascular disease
- dna methylation
- prognostic factors
- patient reported
- protein protein
- young adults
- artificial intelligence
- breast cancer cells
- patient reported outcomes